Sökning: onr:"swepub:oai:DiVA.org:uu-410275" > Adenosine usage dur...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03817naa a2200529 4500 | |
001 | oai:DiVA.org:uu-410275 | |
003 | SwePub | |
008 | 200514s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4102752 URI |
024 | 7 | a https://doi.org/10.1007/s10840-020-00744-82 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a van Rosmalen, Frank4 aut |
245 | 1 0 | a Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry. |
264 | c 2020-04-30 | |
264 | 1 | b Springer Science and Business Media LLC,c 2021 |
338 | a print2 rdacarrier | |
520 | a BACKGROUND: Adenosine can be used to reveal dormant pulmonary vein (PV) conduction after PV isolation (PVI). This study presents a subanalysis of real-world 1-year follow-up data from the ESC-EHRA EORP Atrial Fibrillation (AF) Ablation Long-Term registry to analyze the usage of adenosine during PVI treatment in terms of rhythm outcome and safety.METHODS: The registry consists of 104 participating centers in 27 countries within the European Society of Cardiology. The registry data was split into an adenosine group (AG) and no-adenosine group (NAG). Procedure characteristics and patient outcome were compared.RESULTS: Adenosine was administered in 10.8% of the 3591 PVI patients included in the registry. Spain, the Netherlands, and Italy included the majority of adenosine cases (48.8%). Adenosine was applied more often in combination with open irrigation radiofrequency (RF) energy (74.7%) and less often in combination with nonirrigated RF energy (1.6%). After 1 year, a higher percentage of the AG was free from AF compared with the NAG (68.9% vs 59.1%, p < 0.001). Adenosine was associated with better rhythm outcome in RF ablation procedures, but not in cryo-ablation procedures (freedom from AF: RF: AG: 70.9%, NAG: 58.1%, p < 0.001, cryo: AG: 63.9%, NAG: 63.8%, p = 0.991).CONCLUSIONS: The use of adenosine was associated with a better rhythm outcome after 1 year follow-up and seems more useful in patients treated with RF energy compared with patients treated with cryo energy. Given the improved rhythm outcome at 1-year follow-up, it seems reasonable to encourage the use of adenosine during RF AF ablation. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a Adenosine | |
653 | a Follow-up | |
653 | a Pulmonary vein isolation | |
653 | a Rhythm outcome | |
653 | a Safety | |
653 | a Cardiology | |
653 | a Kardiologi | |
700 | 1 | a Delhaas, Tammo4 aut |
700 | 1 | a Dagres, Nikolaos4 aut |
700 | 1 | a Arbelo, Elena4 aut |
700 | 1 | a Blomström-Lundqvist, Carinau Uppsala universitet,Kardiologi-arrytmi,Kardiologi4 aut0 (Swepub:uu)carinabl |
700 | 1 | a Crijns, Harry J G M4 aut |
700 | 1 | a Da Costa, Antoine4 aut |
700 | 1 | a Pytkowski, Mariusz4 aut |
700 | 1 | a Sharikov, Nikita4 aut |
700 | 1 | a Laroche, Cécile4 aut |
700 | 1 | a Tavazzi, Luigi4 aut |
700 | 1 | a Brugada, Joseph4 aut |
700 | 1 | a Pison, Laurent4 aut |
710 | 2 | a Uppsala universitetb Kardiologi-arrytmi4 org |
773 | 0 | t Journal of Interventional Cardiac Electrophysiologyd : Springer Science and Business Media LLCg 60, s. 395-406q 60<395-406x 1383-875Xx 1572-8595 |
856 | 4 | u https://link.springer.com/content/pdf/10.1007/s10840-020-00744-8.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-410275 |
856 | 4 8 | u https://doi.org/10.1007/s10840-020-00744-8 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy